Overview
Laurence Michel practices in Paris, France. Mr. Michel is highly rated in 5 conditions, according to our data. His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), Sezary Syndrome, Mycosis Fungoides, and T-Cell Lymphoma.
His clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cutaneous T-Cell Lymphoma (CTCL)Mr. Michel isAdvanced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Mycosis FungoidesMr. Michel isAdvanced. Learn about Mycosis Fungoides.
- Non-Hodgkin LymphomaMr. Michel isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Sezary SyndromeMr. Michel isAdvanced. Learn about Sezary Syndrome.
- T-Cell LymphomaMr. Michel isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Adult Still's DiseaseMr. Michel isExperienced. Learn about Adult Still's Disease.
- ADULT SyndromeMr. Michel isExperienced. Learn about ADULT Syndrome.
- Anaplastic Large Cell LymphomaMr. Michel isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Autosomal Recessive HypotrichosisMr. Michel isExperienced. Learn about Autosomal Recessive Hypotrichosis.
- B-Cell LymphomaMr. Michel isExperienced. Learn about B-Cell Lymphoma.
- Collagen VI-Related MyopathyMr. Michel isExperienced. Learn about Collagen VI-Related Myopathy.